JAZZ vs TREE · P/E 1988, rev $4.07B vs P/E 2.8, rev $900.2M
Jazz Pharmaceuticals PLC (JAZZ) versus Lendingtree Inc (TREE) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Lendingtree Inc (TREE) is a financial conglomerates company listed on NASDAQ.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported TREE revenue for 2024-12-31 was $900.2M. Net income was -$41.7M. Revenue was up 33.9% from 2023-12-31 to 2024-12-31. TREE currently screens at market cap $499.8M and trailing P/E 2.8.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. TREE currently screens at market cap $499.8M and trailing P/E 2.8.
Not investment advice. Open the JAZZ and TREE stock pages for the full models.
Not investment advice.